Related Experiment Video
Updated: Jun 4, 2026
09:50
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Flavonoids and the CNS
1Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, 2 Universitetsparken, 2100 Copenhagen, Denmark. ankj@farma.ku.dk
Molecules (Basel, Switzerland)
|February 12, 2011
Summary
Flavonoids, plant compounds found in food, influence health and mood by affecting the central nervous system. These compounds offer neuroprotection and may act as antidepressants or aid Parkinson's patients.
Area of Science:
- Plant biochemistry
- Neuropharmacology
Background:
- Flavonoids are ubiquitous plant compounds with diverse structures, providing UV protection and color.
- Found in food and medicinal plants, they are consumed by humans as glycosides.
Purpose of the Study:
- To explore the absorption, metabolism, and central nervous system (CNS) effects of dietary flavonoids.
- To investigate the potential therapeutic applications of flavonoids in neurological and mood disorders.
Main Methods:
- Description of flavonoid structure and classification.
- Overview of flavonoid absorption and metabolic pathways (deglycosylation, conjugation).
- Summary of CNS penetration and receptor interactions (GABA(A)-receptor, MAO inhibition).
Main Results:
- Absorbed flavonoid aglycones and conjugates can cross the blood-brain barrier.
- Certain flavones exhibit CNS effects via the GABA(A)-receptor, including sedation and anticonvulsion.
- Flavonoids inhibit monoamine oxidase A or B, suggesting antidepressant and Parkinson's therapeutic potential.
- Specific flavonoid subclasses demonstrate anti-inflammatory and neuroprotective effects.
Conclusions:
- Flavonoids possess neuropharmacological activities, influencing CNS functions and potentially mood.
- Dietary flavonoids may offer therapeutic benefits for neurological conditions and mood disorders.
- Further research into flavonoid mechanisms and applications is warranted.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
00:49The Blood-brain Barrier
Overview
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...